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Summary: The effect of increased brain GABA levels on fully kindled amyg- 
dala seizures was investigated in Long-Evans rats. The newly synthesized 
GABA-transaminase inhibitor, y-acetylenic GABA (GAG) administered on 
four consecutive days (100 mg/kg, followed by 50 mg/kg, i.p.) was found to 
either significantly reduce, or eliminate entirely, the behavioral seizures nor- 
mally produced by amygdala stimulation. The effect is seen after the first 
injection of GAG although its magnitude was greater on subsequent days. 
Behavioral seizures reappeared 2 to 3 days after termination of GAG treat- 
ment. The duration of electrographic seizures (self-sustained amygdala after- 
discharge) was either unchanged or greater on the first day of GAG treatment, 
but was briefer on subsequent days. The duration of afterdischarges returned 
to normal levels 1 to 2 days earlier than the behavioral seizures after the 
termination of GAG. Picrotoxin (1.5-2 mg/kg, i.p.) did not antagonize either 
electrographic or behavioral effects of inhibition produced with GAG. Electri- 
cal stimulation of amygdala delivered during the initial sedation stage induced 
by picrotoxin resulted in further regression of kindled seizures in the majority 
of animals. Although in doses employed, GAG alleviates amygdaloid-kindled 
seizures its use requires caution in view of its ability to reduce arousal level. 
- 
Convulsive disorders a re  commonly 
thought to result from inadequate neural in- 
hibition. Pharmacological therapy directed 
to strengthen this inhibition is generally 
perceived as a desirable maneuver in order 
to antagonize the initiation, development, 
and propagation of focal and generalized 
seizures. Correspondingly, the major can- 
didate for the inhibitory brain transmitter, 
y-aminobutyric acid (GABA), which sup- 
posedly mediates pre- and postsynaptic in- 
hibition (Kmjevie, 1971, 1974; Roberts et 
a l . ,  1970), is implicated in ep i lepsy ,  
whereas GABAergic compounds are per- 
ceived to  be potential anticonvulsants 
(Meldrum, 1975). 
Over the past several years, efforts have 
been made to elevate brain GABA content 
by blocking the GABA catabolizing en- 
zyme,  GABA-transaminase (GABA-T) 
(Caminobutyrate: 2-oxoglutarate amino- 
transferase). Recently, the role of the newly 
s y n t h e s i z e d  G A B A - T  i n h i b i t o r ,  y -  
acetylenic  GABA (GAG) and  y-vinyl 
GABA (GVG), were examined in several 
studies (Jung et al., 1977u,b; Schechter et 
al., 1977u,b). Administered systeniically, 
these compounds produced a sixfold in- 
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crease in GABA brain content (Jung et al., 
1977u,b) and have been reported to block 
audiogenic epilepsy in mice (Schechter et 
al., 1977u,b) and to suppress natural photo- 
sensitive epilepsy in the baboon (Meldrum 
and Horton, 1978). In contrast, Cooper et 
al. (1979) have seen only incomplete pro- 
tection against audiogenic seizures during 
alcohol withdrawal in mice after moderate 
doses and even an increased susceptibility 
to seizures after higher doses of GABA-T 
inhibitors. Wood et  al. (1977) found certain 
delays in hyperbaric oxygen-induced sei- 
zures in mice under GAG, although they 
reported no correlation between the large 
increase in brain GABA content and the 
anticonvulsant action of the compound. 
In a recent pilot study Myslobodsky et al. 
(1979) reported that the effect of GABA-T 
inhibitors ranged from aggravation of 
metrazol-activated convulsions to  the 
amelioration of seizures developed during 
the so-called amygdala kindling produced 
by repeated daily electrical stimulation 
(Goddard, 1967). Actually, little is known 
about the role of the GABAergic system in 
kindled epilepsy (see Wada, 1977 for re- 
view) and the present study was an attempt 
to replicate in another strain of rats earlier 
preliminary observations and to extend and 
quantify the available data. In addition, an- 
ticipating the alleviation of kindled seizures 
by GAG, the GABA antagonist, picrotoxin, 
was chosen as a contrasting drug in order to 
shed further light on the mechanisms un- 




Naive, male pigmented Long-Evans rats 
(Charles River Laboratories, Wilmington, 
Mass.) ranging in weight from 250 to 350 g 
at the start of the experiment were used. 
Animals were housed individually in a 
temperature-regulated vivarium. Water and 
food were available ad libifurn. Day-night 
cycle (14/10) was maintained by artificial 
lighting. 
Electrodes were implanted in the amyg- 
dala, using standard stereotaxic techniques 
(coordinates: 2.5 mm posterior to bregma, 
4.5 mm lateral, 8.0 mm below dura, with 
skull level between bregma and lambda) 7 
to 8 days before the beginning of the kin- 
dling sessions. The electrodes consisted of 
two 0.20 mm diam twisted “316” stainless 
steel wires, bare of teflon insulation only at 
the adjacent tips. The electrodes were at- 
tached to microminiature pins (Winchester 
CD8456), which were fixed to the skull with 
acrylic dental cement reinforced by four 
jeweler’s screws. 
Three animals were implanted with bilat- 
eral cortical, recording electrodes. Holes 
for electrodes, located over the visual cor- 
tex, were drilled with care to avoid damage 
to the dura. A hole for an indifferent elec- 
trode was drilled in the midline over the 
cerebellum. The cortical and indifferent 
electrodes consisted of approximately 1 .O 
mm silver balls (produced by melting insu- 
lated silver wire, 0.1 mm diam) positioned 
on the dura. The wire was presoldered to 
microminiature pins, which were cemented 
to the skull. 
Procedure and  Apparatus  
The rat was connected to a cable and 
placed in the observation chamber (20.5 cm 
x 26.5 x 42.5 cm). Kindling stimulation 
was performed according to the “su- 
prathreshold” procedure of Racine (1972) 
and consisted of a 1-sec duration train of 
50.0 PA, 60 Hz current. Electrical stimula- 
tion was delivered three times a day (with 3 
hr intervals) until the development of motor 
manifestations and continued at a rate of 
one per day, every day. EEG monitored for 
afterdischarge was taken regularly before, 
during, and after the electrographic seizure. 
The duration of the postictal period was 
recorded as long as the behavioral excita- 
tion lasted. 
Drug treatment was initiated after the 
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animals were considered fully kindled, 
using as a criterion the attainment of stage 5 
(Racine, 1972; see below) seizures on at 
least 5 consecutive days. The drug treat- 
ment period lasted 4 days and began with 
‘100 mg/kg of GAG given at 8 to 9 a.m. and 
followed by 50 mg/kg administered at the 
same time on the 3 subsequent days. During 
the treatment period the animals were stim- 
ulated electrically twice a day, at 4 to 5 and 
24 hr after the drug administration. 
The drug doses and time between pre- 
treatment and EEG sessions were chosen 
on the basis of findings indicating that 
GABA brain levels are maximal 4 to 12 hr 
after GVG and GAB administration and 
remain supernormal at 24 hr (Jung et al., 
1977a,b; Schechter et al., 1977a,b; Wood et 
al., 1977). On the last day of this treatment 
animals with inhibited or regressed seizures 
were injected with picrotoxin (1.5-2.0 
mg/kg) immediately after the completion of 
the kindling test in an attempt to antagonize 
the seizure suppression produced by GAG. 
A second kindling test was performed 2 to 3 
hr after the picrotoxin injection. This sec- 
ond test was performed, therefore, 6 to 7 hr 
after the last injection of GAG. 
In order to assess the recovery dynamics 
and to determine the importance of further 
stimulation in this process, the subjects 
were randomly assigned into two equal 
groups. In the first group, the kindling ses- 
sions were continued every day after drug 
treatment termination until at least three 
successive stage 5 seizures occurred. In the 
second group, kindling sessions were dis- 
continued for a 2 to 3 day interval after drug 
treatment, renewed after this interval and 
likewise continued until at least three con- 
secutive stage 5 seizures occurred. 
In an auxiliary study conducted with five 
rats, an estimate of the behavioral and EEG 
responses to picrotoxin ( 1  .O-4.0 mg/kg) 
alone was made. After injection of picro- 
toxin the behavioral and EEG changes were 
monitored. Special emphasis was given to 
the time of appearance of changes in pos- 
ture, motility, ability to rear with forelimbs 
hanging free, and to epileptiform activity 
(isolated jerks, multiple jerks, grand ma1 
seizures, postictal behavior). 
Drugs 
y-Acetylenic GABA (Merrell Research 
Center, Cincinnati, Ohio) and picrotoxin 
(Abbott Laboratories, Toledo, Ohio) were 
dissolved in sterile saline and injected in- 
traperitoneall y . 
Definitions 
The term seizure refers to behavioral 
convulsions unless specifically mentioned 
otherwise. Electrographic convulsions in 
kindled animals are denoted as afterdis- 
charges. Postictal excitation is a behavioral 
syndrome and in kindled rats it consists of 
an intense startle reaction, jumping, and 
struggling when an attempt is made to han- 
dle them or when they are touched at the 
base of the tail, neck or body. Undisturbed 
rats do not display postictal excitation. 
Data Reduction and Scoring 
The pattern of convulsions was noted and 
classified according to the stages described 
by Racine (1972). Briefly, this classification 
consists of the following: Stage 0, no motor 
response; stage 1, mouth and facial move- 
ments; stage 2, head nodding; stage 3, 
forelimb clonus; stage 4, rearing; stage 5, 
rearing and falling with loss of postural 
control. This classification scheme was 
supplemented with stage 6, multiple (more 
than one) rearing and falling. EEG record- 
ing was compared with the event recording 
made on the same paper to denote the du- 
ration of the seizure and the postictal exci- 
tation (Fig. 1) .  
RESULTS 
Effects of GAG on Kindled Seizures 
All animals exhibited a stage 5 or 6 sei- 
zure within 6 to 12 stimulation sessions (8.8 
& 4.25 SD) and the pre-GAG baseline crite- 
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FIG. 1. An example of amygdaloid self-sustained afterdischarge and postictal spiking with the event recording 
(second channel) indicating the duration of the behavioral seizure and postictal excitatory period (arrows). 
rion (five consecutive stage 5 seizures) was 
reached at a mean of 18.25 (8.98 SD) ses- 
sions. GAG treatment produced noticeable 
changes in the animals' behavior, consist- 
ing of reduced motility and exploratory ac- 
tivity, arousal decrement, slight ataxia, and 
somnolence. Although these effects were 
not quantified, evidence of toxicity was not 
always as evident after the third injection, 
when animals exhibited normal exploration 
of the test cage 24 hr after an injection, but 
they tended to be less mobile and more 
somnolent than untreated animals during 
the test administered 4 hr after an injection. 
GAG administration resulted in a varying 
degree of synchronization of EEG that 
tended to build up with successive injec- 
tions. The major EEG effect produced by 
GAG was a burst of paroxismal waves or 
wave-spike discharges of 3 to 5 Hz as de- 
scribed elsewhere (Myslobodsky et  al., 
1979; Valenstein and Myslobodsky, sub- 
mitted). 
The effects of repeated GAG administra- 
tion on the seizure intensity and the after- 
discharge are shown in Fig. 2. It can be 
seen from the figure that there is a consid- 
erable regression in the seizure intensity 
stage after GAG trdatment (Fig. 2B). In 8 of 
the 12 animals tested after five consecutive 
stage 5 or 6 seizures, a stage 0 response 
occurred at least once during GAG treat- 
ment. Only in five animals was any stage 5 




FIG. 2. Duration of the afterdischarge (A) and be- 
havioral seizure stage (B) as a function of GAG treat- 
ment time course. The ordinate in A represents the 
afterdischarge duration in sec 2 SD (shaded area): the 
ordinate in B represents seizure stage according to 
Racine (1972) with stage 6 added to denote multiple 
rearing and falling. Pre-drug duration of the afterdis- 
charge and seizure stage is represented by the average 
of the five days preceding the first GAG administra- 
tion. 
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treatment and these were seen on less than 
one-half the tests. Moreover, these seizures 
were noticeably different from normal stage 
5 seizures in that they occurred after a long 
latency, they had a shorter duration, and 
thky were seldom followed by postictal ex- 
citation. 
An attempt was made to induce more se- 
vere seizures in animals during the period 
of GAG treatment, by increasing the 
stimulation duration from 0.5 to 3.0 sec. 
Only in seven trials of the 21 conducted 
with five rats did this long-duration 
stimulus produce a stage 5 seizure. In gen- 
eral, the regression of seizures appeared to 
be greater at 4 hr after GAG treatment than 
24 hr (data not shown). Paradoxically, the 
afterdischarge duration either did not 
change, or it actually increased during the 
first day of drug administration. Its duration 
decreased during subsequent treatment and 
recovered within 1 to 2 days after GAG ad- 
ministration was discontinued (Fig. 2A), 
anticipating the full recovery of behavioral 
seizures by a day or two. 
In the six animals tested daily after the 
termination of GAG injection, behavioral 
seizures were regressed or totally absent 
for 2 to 3 days. This effect is probably due 
to residual supranormal levels of brain 
GABA. The gradual return to more severe 
seizures does not seem to depend on the 
stimulation trials as the other six rats, 
which were given an interval of 2 to 3 days 
without stimulation after the termination of 
GAG treatment, exhidited stage 5 to 6 sei- 
zures on the first post-drug test. 
Effects of GAG on the duration of stage 5 
fits and the postictal excitation Cjumping, 
running, biting) observed during handling is 
shown in Table 1. It can be seen from this 
table that the duration of the occasional 
stage 5 seizures that occurred did not 
change, but these were followed by a re- 
duction in postictal excitation. This reduc- 
tion showed some tendency to persist into 
the post-drug recovery period, remaining 
somewhat lower in the recovery period. 
Effect of Picrotoxin 
Although picrotoxin is generally regarded 
as belonging to a group of analeptic com- 
pounds (Wang and Ward, 1977) its excit- 
atory action occurs with a considerable 
delay. In fact, the first effect to develop 
after the administration of 1.5 to 4.0 mg/kg 
of picrotoxin is an inhibitory one, charac- 
terized behaviorally by a stage of sedation 
and ataxia. Electrographically, this stage is 
characterized by a buildup of EEG syn- 
chronization culminating with 7 Hz 
spindle-shaped paroxismal bursts of spin- 
dles and wavespikes (Fig. 3A). This stage 
lasts for 5 to 20 min and, with doses 2 mg/kg 
and higher, is terminated by the develop- 
ment of isolated head or head-body myo- 
clonic jerks classified as stage 2 of the pic- 
rotoxin effect. Electrographically, stage 2 is 
characterized by a gradual replacement of 
the relatively smooth waxing and waning 
shape of the spindles by spindles preceded 
by a single spike, which regularly accom- 
panied the appearance of a myoclonic jerk 
(Fig. 3B). The frequency of the spindles 
also decreased to 4 to 5 Hz during stage 2. 
Stage 3 was designated when the animal 
displayed multiple, myoclonic jerks corre- 
sponding to the development of 2 to 3 
TABLE 1. Dirration o j  behavioral seizrrres and latency rind dirrrrtion 
ojpostictal excitation (mean and S E M )  
Behavioral Postictal Postictal 
seizure excitation excitation 
State duration latency duration 
he-drug 37.20 r 2.38 27.28 ? 1.51 92.69 2 7.51 
GAG 37.5 2 4.02 34.14 2 4.9 21.76 ? 7.49 
Recovery 40.87 1.88 29.5 2 1.54 60.63 2 9.57 
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spikes at the beginning of spindles, that 
either assumed the form of an afterdis- 
charge (in the mild cases) (Fig. 3C) or the 
EEG was entirely disorganized, containing 
numerous polyspikewave dischargds lead- 
ing eventually to a behavioral and electro- 
graphic grand ma1 convulsion (stage 4) (Fig. 
3D). Depending on the sensitivity of the 
animal, stage 4 could develop with a dose of 
2 mg/kg, although it usually requires higher 
doses than were explored in the present 
study. 
Figure 4 demonstrates that picrotoxin 
administered to the GAG-treated rats did 
not antagonize GAG produced synchroni- 
zation, but rather facilitated it as expressed 
by the intensification of the abnormalities in 
the EEG. It was anticipated that picrotoxin 
would increase the severity of the kindled 
convulsions that had been attenuated by 
GAG. However, the seizure intensity pro- 
duced by amygdala stimulation delivered 
during the picrotoxin sedation period (stage 
1) was further attenuated in the three ani- 
mals that were still showing some seizures. 
In three other GAG-treated animals that 
were not showing any seizures, no effect of 
picrotoxin could be detected. 
DISCUSSION 
The present findings demonstrate that the 
GABA-T inhibitor, GAG, may significantly 
attenuate or totally suppress the motor 
convulsions produced by amygdala kin- 
dling. An increase in the GABAergic brain 
levels seems to have a less consistent effect 
on the amygdaloid seizure afterdischarge. 
Particularly on the first test after GAG in- 
jection, but also during the recovery period 
after the termination of drug treatment, 
there tended to be a dissociation of after- 
discharge duration from the intensity of the 
seizure. On the first post-GAG test the af- 
terdischarge duration was often increased 
or unchanged even where motor convul- 
sions were totally suppressed. In a few in- 
stances, however, the afterdischarge dura- 
tion did decrease on the first post-drug test. 
A similar dissociation between motor con- 
vulsions and EEG produced by GAG was 
found in the total suppression of myoclonic 
responses in photosensitive baboons at a 
time when the EEG continued to show ab- 
normal epileptiform activity (Meldrum and 
Horton, 1978). 
This partial dissociation of the electro- 
graphic seizure from its behavioral accom- 
p a n i m e n t  i s  h a r d l y  a r e s u l t  o f  t h e  
myotonolytic effect that GABA agonists 
are known to possess (Carlidge et al., 1974; 
Feldman et al., 1978). When the duration of 
the electrical stimulation was increased, it 
proved possible to induce motor seizures 
that appeared identical, electrophysiologi- 
cally and behaviorally, to the original sei- 
zures observed before to GAG treatment. 
This dissociation between the behavioral 
and EEG manifestations of seizures is dif- 
ficult to explain. The phenomenon seems to 
violate the “all-or-none’’ principle de- 
scribed for mature kindled seizures (Sato 
and Nakashima, 1975; Wada and Sato, 
1975). The maturation of the kindling pro- 
cess is generally believed to depend on the 
gradual buildup of the stimulation-induced 
afterdischarges (Racine, 1972). With con- 
tinuation of stimulation the motor accom- 
paniment gradually reaches the magnitude 
of stage 5 convulsions, a process thought to 
indicate that kindling “strengthens” or 
“creates” the output to the motor system 
(Goddard and Douglas, 1975). The ability of 
this process to “regress” under the GAG 
treatment condition may imply that the 
connections to the output apparatus are 
controlled or modulated by inhibitory 
GABA neurons. Similarly, other  com- 
pounds such as diazepam and phenobarbi- 
tal, which are reported to  produce afterdis- 
charge behavior dissociation (Wise and 
Chinerman, 1974), may also act through a 
GABAergic system. Diazepam is known to 
mimic both pre- and postsynaptic effects of 
GABA (see Costa, 1977, for review) and it 
has been suggested that benzodiazepines 
produce an  allosteric alteration of the 
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GABA binding sites that increases the ef- 
fectiveness of the GABA action (Guidolli et 
al., in press; cited by Kupferman, 1979). 
Barbituates also potentiate GABA effects 
(Nicoll, 1978; Ransom and Baker, 1976) and 
reverse GABA effects blocked by its an- 
tagonist, bicuculine (Bowery and Dray, 
1976). 
In  spite of the evidence implicating 
GABA in the expression of behavioral sei- 
zures there remain problems for interpret- 
ing the present results with amygdala kin- 
dling. Although GABA is an omnipresent 
amino acid, the largest amounts of this 
neurotransmitter are found in the mesen- 
cephalon, neostriatum, and hippocampus, but 
not in the amygdala (McGeer et al., 1978). 
A relatively high content of glutamic acid 
decarboxylase, however, has been found in 
the amygdaloid complex (Le Gal La Salle et 
al., 1978). In addition, the findings of the 
same  authors  suggest  t ha t  t he re  i s  a 
GABAergic amygdalopetal component 
within the stria terminalis projecting to the 
central, amygdala nucleus although the 
source of these fibers remains unknown. 
Given this uncertainty, and the systemic 
route of GAG administration employed in 
the present study, it is not possible to as- 
cribe the effects observed to any particular 
GABA pathway, or mechanism. 
Catecholamines are also possible candi- 
dates for such GABA-mediated effects. 
They  a r e  implicated in epi lepsy (see 
Maynert et al., 1975) and have a close re- 
lationship with the GABAergic system. 
They also are known to act as endogenous 
antiepileptic compounds in some forms of 
epilepsy due to their participation in high 
arousal states, known to impede seizures. 
Paradoxically, however, GAG has a pow- 
erful anti-seizure effect on a background of 
visible arousal decrement as evidenced by 
the decreased motility in rats, EEG syn- 
chronization, and even hypersynchroniza- 
tion (Myslobodsky et al., 1979; Valenstein 
and Myslobodsky, in preparation). A de- 
crease in arousal level, somnolence, and 
slow-wave sleep are known to facilitate in- 
terictal amygdaloid spiking in kindled ani- 
mals (Tanaka et al., 1975). 
A number of GABAergic compounds 
have a distinct soporific effect (Anden et 
al., 1973; Roberts and Simonsen, 1966; 
Scotti de Carolis and Massotti, 1978) simi- 
lar to GAG. This phenomenon is not well 
understood although it is often interpreted 
as indicating the ability of GABA to control 
t he  ac t iv i ty  o f  dopamine-conta in ing  
neurons, with corresponding decrease in 
dopamine turnover rate. Recently, Pal- 
freyman et al. (1978) reported a decrease in 
homovanillic acid in the striatum, but not in 
the nucleus accumbens, after administra- 
tion of 100 mg/kg of GAG, suggesting that 
GAG decreases striatal dopamine turnover. 
It is well known, however, that the neo- 
striatum has an inhibitory effect on amyg- 
daloid seizures (Fariello, 1976; La Grutta et 
al., 1971), whereas accumbens stimulation 
generally has no detectable effect (Fariello, 
1976). Therefore, if dopamine is involved in 
epilepsy control (see Maynert et al., 1973, 
its role in suppressing kindled seizures 
seems obscure in view of these findings. 
Some indications of the facilitation of the 
kindling process after stria terminalis le- 
sions (Engel and Katzman, 1977) may be 
interpreted (Le Gal La Salle et al., 1978) as 
related to the loss of GABAergic, but not 
dopaminergic, control  ove r  amygdala 
neurons. 
The other catecholamine, norepineph- 
rine, is also known to interfere with con- 
vulsive disorders in general (Maynert et al., 
1975) and with kindled seizures in particular 
(Corcoran et al., 1974). The norepinephrine 
neurons of the locus coeruleus project to 
practically all divisions of the amygdaloid 
complex (Fallon et al., 1978). In addition, 
the turnover of norepinephrine in the  cen- 
tral nervous system reportedly has been 
facilitated by GABA under in vivo condi- 
tions in the rat (Biswas.and Carlsson, 1977). 
These GABA effects on norepinephrine 
transmission are not affected by picrotoxin 
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(Biswas and Carlsson, 1977u,b), which is 
consistent with the present findings that 
picrotoxin is unable to  antagonize the 
GAG-inhibited seizures. Therefore, it is 
possible that the increase in GABAergic 
levels leads to seizures suppression through 
the mediation of the dorsal norepinephrine 
system, although this remains to be proven. 
Effect of Picrotoxin 
Being an inhibitory transmitter, GABA is 
probably involved in the generation of the 
“inhibitory synchronous activity.” In fact, 
sleep spindles (Andersen and Andersson, 
1968), certain categories of delta waves 
(Ball et al., 1977), sensory theta activity in 
rodents (Guselnikov and Supin, 1968), 
“pleasure rhythms,” and wave-spike dis- 
charges (Myslobodsky, 1976; see also for 
review) are all supposedly organized due to 
a phasing of depolarizing potentials with the 
long lasting waves of postsynaptic inhibi- 
tion. Since picrotoxin activates a similar 
type of E E G  hypersynchronization as 
found with GAG, the effects of the two 
compounds must  have summated.  Al- 
though this hypersynchronization was cur- 
rently seen to facilitate spiking in the amyg- 
dala as  was also reported in natural sleep 
(Tanaka e t  al . ,  1975), it seemingly an- 
tagonizes actual seizures,  that is ,  self- 
sustained afterdischarges. A conceivable 
analogy to  this effect is the increased 
threshold for grand ma1 seizures during 
slow-wave sleep and the decrease during 
REM sleep. In fact, high frequency electri- 
cal stimulation that produces an arousal 
reaction reportedly reduces the latency of 
kindled grand ma1 convulsions (Tanaka et  
al., 1975) whereas d-amphetamine tends 
t o  p r o l o n g  a m y g d a l o i d  c o n v u l s i o n s  
(Babington and Wedeking, 1973). The na- 
ture of this effect is discussed at  length 
elsewhere (Myslobodsky, 1976) and is 
mentioned here to emphasize that although 
p i c r o t o x i n  a n d  G A G  p r o d u c e  a n  
epileptiform-like EEG pattern it may in fact 
hyperpolarize the same pool of neurons that 
need to be depolarized by amygdaloid 
electr ical  s t imulat ion t o  induce  self-  
sustained afterdischarges. 
Another problem requiring discussion is 
why picrotoxin, a compound long known to 
an tagonize  GABAergic  t ransmiss ion ,  
should not eliminate rather than potentiate 
the sedation and wave-spike activity in- 
duced by GAG. A likely explanation of this 
effect stems from the fact that whereas pic- 
rotoxin ac ts  presynapt ical ly ,  the  da ta  
suggest that GABA mediates both pre- and 
postsynaptic inhibition (Roberts e t  al., 
1970). These facts invite the speculation 
that whereas increases in GABA levels 
produce synchronization and somnolence 
predominantly by postsynaptic action, pic- 
rotoxin may exaggerate the activity of post- 
synaptic inhibition by blocking GABA- 
mediated depolarization on the terminal 
branches of inhibitory interneurons. 
Although attractive, this proposed expla- 
nation of the potentiation of GAG effects by 
picrotoxin rests on several assumptions. 
First, the hypothesis depends on the exis- 
tence of synaptic inhibitory synapses lo- 
calized on  the  ferminals of inhibitory 
neurons. Although picrotoxin has long 
since been implicated in presynaptic inhibi- 
tion (see Levy, 1977 for review) there is no 
direct evidence in support of this assump- 
tion. It should be noted, however, that 
there are precedents for this type of mecha- 
nism. For example, “inhibition of inhibi- 
tion” is believed to operate in the visual 
cor tex (Skrebitsky, 1967), neostriatum 
(Buchwald et al., 1967), and thalamus (Pur- 
pura et al., 1966). 
In addition, the hypothesis requires that 
postsynaptic inhibition should be relatively 
more powerful in the brain than presynaptic 
inhibition. In the opposite case, the effect 
of the GABA level increase at postsynaptic 
sites would be opposed by the parallel in- 
crease in potency of the presynaptic inhibi- 
tion operating on the output of the inhib- 
itory interneurons, and the net result of 
GAG would be insignificant. There is little 
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direct evidence available, but some support 
for our hypothesis may be derived from the 
belief that although presynaptic inhibition 
has an important role in the thalamus, it is 
generally far less effective at the higher 
levels of the brain than in the spinal cord 
(see McGeer et al., 1978). 
Finally, the ability of picrotoxin to  
potentiate EEG and behavioral effects of 
GAG suggests that there may be at least 
two types of GABA receptors, only one of 
which is blocked by picrotoxin, as was re- 
cently suggested by Krnjevie (1971). Alter- 
native possibilities are that picrotoxin could 
have partial GABA agonistic activity. In 
any event, the results of these experiments 
would appear to justify the further analysis 
of picrotoxin effects on kindled seizures. 
Practical Implications 
These findings along with recently re- 
ported data on the beneficial effects of 
GAGA treatment in audiogenic epilepsy, 
alcohol withdrawal epileptiform syndrome, 
and photosensitive epilepsy (see introduc- 
tory section) suggest that this compound 
has important antiepileptic properties that 
should attract the attention of epileptologists. 
As a note of caution one should remember 
that GAG-produced EEG hypersynchroni- 
zation may reach an undesirable magnitude 
and interfere with arousal level and perfor- 
mance of the subjects (Valenstein and 
Myslobodsky, submitted). 
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RESUME 
L’effet de I’tltvation des taux ctrkbraux de GABA 
sur les crises amygdaliennes par effet d’embrasement 
complet a t t t  ttudik chez des rats Long-Evans. L’in- 
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jection pendant 4 jours conskcutifs de 100 mdkg suivis 
de 50 mdkg i.p. d’un inhibiteur de la GABA. Trans- 
aminase nouvellement synthetise (y-acetylenic GABA 
ou GAG) a significativement rkduit ou mCme supprime 
les crises normalement provoquees par la stimulation 
amygdalienne. L’effet est observe aprks la premiere 
injection de GAG, mais son importance s’accroit les 
jours suivants. Les crises rkapparaissent 2 ou 3 jours 
aprks la fin du traitement au GAG. Du point de vue 
klectrographique, la durke de la postdecharge amyg- 
dalienne autoentretenue est inchangte ou accrue le 
premier jour du traitement, mais elle diminue les jours 
suivants pour retourner B la normale un ou deux jours 
avant que les crises ne rtapparaissent aprks la fin de 
I’administration du GAG. L’injection de picrotoxine 
(1.5-2 mdkg i.p.) ne s’oppose pas aux effets inhib- 
iteurs du GAG sur les crises ou leur accompagnement 
EEG. La stimulation electrique de I’amygdala pendant 
I’Ctape sedative initiale induite par la picrotoxine pro- 
voque une rkgression supplementaire des crises d’em- 
brasement chez la majoritk des animaux. Bien que, 
aux doses utiliskes, le GAG attenue les crises amyg- 
daliennes d’embrasement, son utilisation nkcessite des 
precautions compte tenu de sa tendance B rkduire le 
niveau d’kveil. 
( J .  L. Gastaut, MorseiNes) 
RESUMEN 
En ratas Long-Evans se ha investigado el efecto del 
aumento de 10s niveles cerebrales de GABA, sobre 10s 
ataques originados en la amigdala totalmente con- 
dicionada, (Kindling). El recientemente sintetizado in- 
hibidor de la GABA transaminasa, y-acetilenico 
GABA (GAG), redujo significativamente o elimin6 
totalmente las crisis de comportamiento que habitu- 
almente se producen con la estimulaci6n de la am‘g- 
dala. El efecto se observa desputs de la primera in- 
yecci6n de GAG per0 su magnitud aument6 en dias 
subsiguientes. Las crisis de comportamiento 
reaparecieron a 10s 2-3 dias de la intermpcidn del 
tratamiento con GAG. La duraci6n de 10s ataques 
electrogrhficos (perservaci6n de la post-descarga de la 
amigdala) no se modificb, o incluso aument6, en el 
primer dia de la administracibn de GAG per0 se redujo 
en 10s dias siguientes. La duraci6n de las post- 
descargas volvi6 a sus niveles normales 1 o 2 dias 
antes que la reaparici6n de las crisis de compor- 
tamiento una vez terminado el tratamiento con GAG. 
La picrotoxina ( 1  3 - 2  mg/kg, i.p.) no antagonizb 10s 
efectos inhibitorios producidos por el GAG sobre el 
electroencefalograma o las crisis de comportamiento. 
La estimulaci6n eltctrica sobre la amigdala, aplicada 
durante la fase de sedaci6n inicial inducida por la pic- 
rotoxina, condujo a una regresi6n a6n mhs intensa de 
las crisis condicionadas, en la mayoria de 10s animales. 
A pesar de que, con las dosis utilizadas, el GAG alivia 
las crisis de la amigdala previamente condicionada, se 
requiere gran precauci6n en su utilizaci6n en vista de 
su propiedad de reducir el nivel del despertar. 
(A. Portera Sanchez, Madrid) 
ZUSAMMENFASSUNG 
Die Wirkung erhohter GABA-Spiegel des Gehirns 
auf Amygdalonkrampfe nach Kindling wurden bei 
Long-Evans-Ratten untersucht. Der neuerdings syn- 
thetisierte GABA-Transaminasen-Inhibitor, Gamma- 
Acetylen-GABA (GAG) wurde an 4 aufeinander- 
folgenden Tagen in einer Dosis von 100 m a g  und 
anschlieknd 50 m a g  i.p. verabfolgt. Er reduzierte 
entweder signifikant oder eliminierte vdllig die anfalls- 
weisen Verhaltensanderungen, die normalerweise 
durch Stimulation des Amygdalon produziert wurden. 
Die Wirkung ist nach der Erstinjektion des GAG zu 
beobachten, obgleich ihr AusmaB an folgenden Tagen 
grdBer war. Die Verhaltensanfdle kamen 2 bis 3 Tagen 
nach Beendigung der GAG-Behandlung wieder: Die 
Dauer der elektrographischen Anfdle (sich selbst un- 
terhaltende Amydalonnachentladungen) blieben 
entweder gleich oder sie wurden gr6Ber am 1. Tag 
der GAG-Behandlung, wurden aber kiirzer an fol- 
genden Tagen. Die Dauer der Nachentladungen nor- 
malisierte sich 1 bis 2 Tage friiher als die Verhal- 
tensanfalle nach Beendigung des GAG verschwanden. 
Picrotoxin (1.5 bis 2 mg/kg i.p.) wirken nicht als 
Antagonist gegeniiber der durch GAG produzierten 
Hemmung der elektrographischen-oder Verhalten- 
seffekte. Die elektrische Stirnulierung des Amygdalon 
wahrend der initialen Sedierung nach Picrotoxin ver- 
ursachte bei der Mehrzahl der Tiere einen weiteren 
Riickgang der durch Kindling entstandenen Anfalle. 
Obgleich das GAG in den verwandten Dosen, die 
durch Kindling des Amygdalon erzeugten Krampfe 
leichter ablaufen la&, erfordert seine Anwendung 
Vorsicht hinsichtlich seiner Fahigkeit, das Erreg- 
barkeitsniveau zu senken. 
(D. Scheffner, Heidelberg) 
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